These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 10809401)

  • 1. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R; Müller T; Riess O
    J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein and Parkinson's disease.
    Lücking CB; Brice A
    Cell Mol Life Sci; 2000 Dec; 57(13-14):1894-908. PubMed ID: 11215516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T
    J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K
    Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
    Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
    Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
    Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
    Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
    Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
    Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.